Home
/
BOSTON SCIENTIFIC CORP
/
Financials
/
Quarterly
BOSTON SCIENTIFIC CORP — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that BOSTON SCIENTIFIC CORP filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2017
Sep 30, 2017
$2.22B
Nov 2, 2017
Q2
2017
Jun 30, 2017
$2.28B
Aug 3, 2017
Q1
2017
Mar 31, 2017
$2.20B
May 3, 2017
Q3
2017
Sep 30, 2016
$2.10B
Nov 2, 2017
Q2
2017
Jun 30, 2016
$2.13B
Aug 3, 2017
Q1
2017
Mar 31, 2016
$2.00B
May 3, 2017
Q3
2016
Sep 30, 2015
$2.04B
Nov 3, 2016
Q2
2016
Jun 30, 2015
$1.98B
Aug 3, 2016
Q1
2015
Mar 31, 2015
$1.89B
May 6, 2015
Q3
2015
Sep 30, 2014
$1.86B
Nov 4, 2015
Q2
2015
Jun 30, 2014
$1.87B
Aug 6, 2015
Q1
2015
Mar 31, 2014
$1.78B
May 6, 2015
Q3
2014
Sep 30, 2013
$1.74B
Nov 5, 2014
Q2
2014
Jun 30, 2013
$1.79B
Aug 6, 2014
Q1
2014
Mar 31, 2013
$1.71B
May 8, 2014
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$5.07B
Nov 3, 2025
Q2
2025
Jun 30, 2025
$5.06B
Aug 1, 2025
Q1
2025
Mar 31, 2025
$4.66B
May 1, 2025
Q3
2025
Sep 30, 2024
$4.21B
Nov 3, 2025
Q2
2025
Jun 30, 2024
$4.12B
Aug 1, 2025
Q1
2025
Mar 31, 2024
$3.86B
May 1, 2025
Q3
2024
Sep 30, 2023
$3.53B
Nov 1, 2024
Q2
2024
Jun 30, 2023
$3.60B
Aug 1, 2024
Q1
2024
Mar 31, 2023
$3.39B
May 1, 2024
Q3
2023
Sep 30, 2022
$3.17B
Nov 1, 2023
Q2
2023
Jun 30, 2022
$3.24B
Aug 3, 2023
Q1
2023
Mar 31, 2022
$3.03B
May 4, 2023
Q3
2022
Sep 30, 2021
$2.93B
Nov 3, 2022
Q2
2022
Jun 30, 2021
$3.08B
Aug 4, 2022
Q1
2022
Mar 31, 2021
$2.75B
May 5, 2022
Q3
2021
Sep 30, 2020
$2.66B
Nov 4, 2021
Q2
2021
Jun 30, 2020
$2.00B
Aug 6, 2021
Q1
2021
Mar 31, 2020
$2.54B
May 6, 2021
Q3
2020
Sep 30, 2019
$2.71B
Nov 5, 2020
Q2
2020
Jun 30, 2019
$2.63B
Aug 5, 2020
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2018
Mar 31, 2018
$2.38B
May 1, 2018
Q3
2017
Sep 30, 2017
$2.22B
Nov 2, 2017
Q2
2017
Jun 30, 2017
$2.26B
Aug 3, 2017
Q1
2018
Mar 31, 2017
$2.16B
May 1, 2018
Q3
2017
Sep 30, 2016
$2.11B
Nov 2, 2017
Q2
2017
Jun 30, 2016
$2.13B
Aug 3, 2017
Q1
2017
Mar 31, 2016
$1.96B
May 3, 2017
Q3
2016
Sep 30, 2015
$1.89B
Nov 3, 2016
Q2
2016
Jun 30, 2015
$1.84B
Aug 3, 2016
Q1
2016
Mar 31, 2015
$1.77B
May 4, 2016
Q3
2015
Sep 30, 2014
$1.85B
Nov 4, 2015
Q2
2015
Jun 30, 2014
$1.87B
Aug 6, 2015
Q1
2015
Mar 31, 2014
$1.77B
May 6, 2015
Q3
2014
Sep 30, 2013
$1.74B
Nov 5, 2014
Q2
2014
Jun 30, 2013
$1.81B
Aug 6, 2014
Q1
2014
Mar 31, 2013
$1.76B
May 8, 2014
Q3
2013
Sep 30, 2012
$1.74B
Nov 5, 2013
Q2
2013
Jun 30, 2012
$1.83B
Aug 7, 2013
Q1
2013
Mar 31, 2012
$1.87B
May 7, 2013
Q3
2012
Sep 30, 2011
$1.87B
Nov 6, 2012
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2010
Sep 30, 2010
$190.00M
Nov 5, 2010
Q2
2010
Jun 30, 2010
$98.00M
Aug 5, 2010
Q3
2010
Sep 30, 2009
($94.00M)
Nov 5, 2010
Q2
2010
Jun 30, 2009
$158.00M
Aug 5, 2010
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$1.05B
Nov 3, 2025
Q2
2025
Jun 30, 2025
$819.00M
Aug 1, 2025
Q1
2025
Mar 31, 2025
$921.00M
May 1, 2025
Q3
2025
Sep 30, 2024
$733.00M
Nov 3, 2025
Q2
2025
Jun 30, 2024
$520.00M
Aug 1, 2025
Q1
2025
Mar 31, 2024
$675.00M
May 1, 2025
Q3
2024
Sep 30, 2023
$693.00M
Nov 1, 2024
Q2
2024
Jun 30, 2023
$514.00M
Aug 1, 2024
Q1
2024
Mar 31, 2023
$552.00M
May 1, 2024
Q3
2023
Sep 30, 2022
$358.00M
Nov 1, 2023
Q2
2023
Jun 30, 2022
$423.00M
Aug 3, 2023
Q1
2023
Mar 31, 2022
$466.00M
May 4, 2023
Q3
2022
Sep 30, 2021
$387.00M
Nov 3, 2022
Q2
2022
Jun 30, 2021
$262.00M
Aug 4, 2022
Q1
2022
Mar 31, 2021
$370.00M
May 5, 2022
Q3
2021
Sep 30, 2020
($205.00M)
Nov 4, 2021
Q2
2021
Jun 30, 2020
($71.00M)
Aug 6, 2021
Q1
2021
Mar 31, 2020
$146.00M
May 6, 2021
Q3
2020
Sep 30, 2019
$383.00M
Nov 5, 2020
Q2
2020
Jun 30, 2019
$384.00M
Aug 5, 2020